
Sign up to save your podcasts
Or


A Fifth Circuit ruling that keeps mifepristone available, but curtails access to it, is the newest front in a battle over the FDA’s power to approve medications.
Read the story here.
By WIRED4.3
5656 ratings
A Fifth Circuit ruling that keeps mifepristone available, but curtails access to it, is the newest front in a battle over the FDA’s power to approve medications.
Read the story here.

3,992 Listeners

26,396 Listeners

9,513 Listeners

488 Listeners

100 Listeners

50 Listeners

87,170 Listeners

112,394 Listeners

60 Listeners

24,291 Listeners

77 Listeners

5,463 Listeners

398 Listeners

29,199 Listeners

15,966 Listeners

2,283 Listeners

3,426 Listeners